https://www.selleckchem.com/products/tak-715.html
05; 95% CI 1.03-1.08; p 0.01), tracheostomy (OR 3.52; 95% CI 1.90-6.75; p 0.01), hospitalisation 3 months prior to admission (OR 2.07; 95% CI 1.17-3.71; p 0.01), vancomycin use (OR 3.31; 95% CI 2.02-5.18; p 0.01), and macrolide use (OR 3.31; 95% CI 1.43-7.76; p 0.01). Macrolide use was a risk factor for CPE acquisition. This association should be evaluated further, especially in developing countries. Macrolide use was a risk factor for CPE acquisition. This association should be evaluated further, especially in
Like
Comment
Share
